SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY

Cara De Galan  ¹     Marie Truyens  ¹     Harald Peeters  ²     Francisco Mesonero Gismero  ³     Ainara Elorza  ⁴     Paola Torres  ⁵     Liv Vandermeulen  ⁶     Aranzazu Jauregui Amezaga  ⁷     Rocío Ferreiro-Iglesias  ⁸     Tom Holvoet  ⁹     Yamile Zabana  ¹⁰     Laia Peries Reverter  ¹¹     Jeroen Geldof  ¹¹     Martine De Vos  ¹¹     Triana Lobaton  ^11    
1 Ghent University, Ghent, Belgium
² AZ Sint Lucas, Ghent, Belgium
³ Hospital Ramon y Cajal, Madrid, Spain
⁴ Hospital de Galdakao, Bilbao, Spain
⁵ Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
⁶ Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium
⁷ University Hospital Antwerp, Antwerp, Belgium
⁸ Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
⁹ AZ Nikolaas, Sint-Niklaas, Belgium
¹⁰ Hospital Universitari Mutua de Terrassa, Barcelona, Spain
¹¹ Hospital Universitari de Girona, Girona, Spain

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)